156 -2 (30/2) 2020 — Hasanov V.R., — CLINICAL AND ULTRASOUND CHARACTERISTICS OF TREATMENT OF PATIENTS WITH ACUTE THROMBOSIS OF DEEP LOWER EXTREMITY

CLINICAL AND ULTRASOUND CHARACTERISTICS OF TREATMENT OF PATIENTS WITH ACUTE  THROMBOSIS OF DEEP LOWER EXTREMITY

Hasanov V.R.,-Tashkent Medical Academy, 100109, Uzbekistan Tashkent Farobi 2 http://tma.uz/ru/.

Resume

The article is dedicated to the study of the effectiveness, immediate and long-term results, according to ultrasound examination, catheter-aspiration thrombectomy, thrombolysis and antiplatelet therapy in patients with acute vein thrombosis of the lower extremities, since there is no consensus in the available literature on the feasibility and results of endovascular catheter-aspiration thrombectomy and thrombolysis with thrombosis of the veins of the lower extremities.

Key words: clinical ultrasound, acute thrombosis, lower limbs, emergency surgery, risk. factor.

First page

586

Last page

589

For citation: Hasanov V.R., Clinical and ultrasound characteristics of treatment of patients with acute thrombosis of deep lower extremity//New Day in Medicine 2(30)2020 586-589 https://cutt.ly/svPswKD

List of References

1. Сулимов В.А., Беленцов С.М., Еоловина Н.И. и др. Распрост­раненность и профилактика тромбоэмболий в клинической практике: российские результаты международного регистра ENDORSE. //Клиническая фармакология и терапия. 2008; 17(3): 32-40.
2. Хрыщанович В.Я., Климчук И.П., Калинин С. С., Турлюк Д.В., Роговой Н.А. Результаты применения локального кате­терного тромболизиса у пациентов с илефеморальным фле­ботромбозом// Военная медицина. 2018; 1: 77-82.
3. Beyer-Westendorf J. et al. Venous thromboembolism prevention and treatment: expanding the rivaroxaban knowledge base with real-life data. //European Heart Journal Supplements. 2015; 17 (Suppl. D): D32-D41.
4. Cohen   A.T.,   Agnelli    G.,   Anderson     F.A.   et   al.  Venous Thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. //Thromb Haemost. 2007; 98 (4): 756-764.
5. Heit J.A. Predicting the risk of venous thromboembolism recurrence. //Am J Hematol. 2012; 87(Suppl. 1): 63-67.
6. Jimenez D., de Miguel-Diez J., Guijarro R. et al. Trends in the management and outcomes of acute pulmonary embolism analysis from the RIETE registry. //J Am Coll Cardiol. 2016; 67: 162-70.
7. Khanna A.K., Singh S. Postthrombotic Syndrome: Surgical Possibilities. Thrombosis. 2012; 2012: 1-7.
8. Konstantinides S.V., Torbicki A, Agnelli G. et al. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) // Eur. Heart J. 2014; 35: 3033-3080.
9. Konstantinides S.V. Trends in Pulmonary Embolism Outcomes. Are We Really Making Progress? // J. Am. Col. Cardiol. 2016; 67(2): 171-173.
10. Kyrle P.A., Rosendaal F.R., Eichinger S. Risk assessment for recurrent venous thrombosis // Lancet. 2010; 376(9757): 2032­2039.
11. Papadakis E. et al. DOACs dose adherence during initial and long-term VTE management. Practical implications, findings from the RIETE registry. http://www.gth2017.org/en/ showAbstract/ 546.
12. Schiro T.A., Sakowski J., Romanelli R.J. et al. improving adherence to best-practice guidelines for venous thromboembolism risk assessment and prevention. Am. J. Health. Syst. Pharm. 2011; 68: 2184-2189.
13. Vedantham S.Z., Goldhaber J.A., Julian S.R., Kahn M.R., Jaff D.J., Cohen E., Magnuson M.K., Razavi A.J. at al. Pharmacomechanical Catheter-Directed Thrombolysis for Deep­Vein Thrombosis //New Engl. J. Med. 2017; 377(23): 2240-2252.